title: [Efficacy of the combination of cycloferon and reamberin in treatment of resistant patients with paranoid schizophrenia].
abstract: The 160 patients with paranoid schizophrenia (PSH) with neuroleptic therapeutic resistance (TR) was investigated. The 90 (basic group) patients got of modern detoxic and metabolically active preparation reamberin and immunotropic facilities cycloferon combination additionally to psychotropic preparations and 70 patients (comparison group) - only the generally accepted therapy. Positive influence of reamberin and cycloferon combination was set on clinical states at the patients of PSH such as disease remission, and endogenous toxicosis syndrome liquidation. Positive influence of this preparations combination was rationed on immunological indexes, characterizing composition and functional activity of cellular immunity.
authors.forename: N A
authors.initials: NA
authors.lastname: Maruta
authors.forename: G S
authors.initials: GS
authors.lastname: Rachkauskas
authors.forename: V M
authors.initials: VM
authors.lastname: Frolov
authors.forename: I F
authors.initials: IF
authors.lastname: Tereshina
mesh_terms: D000166:Acridines / Q000627:therapeutic use*; D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D008297:Male; D008536:Meglumine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D013386:Succinates / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000166:Acridines; D007369:Interferon Inducers; C549374:Reamberin; D013386:Succinates; D008536:Meglumine; C026430:10-carboxymethyl-9-acridanone